- Yoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
-
Lee JH
- KMID: 2534249
- J Liver Cancer.
- 2022 Sep;22(2):207-207.
- doi: 10.17998/jlc.21.1.58.e1
-
- CITED
-
- Close
- SHARE
-
- Close
- Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
-
Lee HW
- KMID: 2534235
- J Liver Cancer.
- 2022 Sep;22(2):91-92.
- doi: 10.17998/jlc.2022.09.20
-
- CITED
-
- Close
- SHARE
-
- Close
- Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
-
Na SK
- KMID: 2534244
- J Liver Cancer.
- 2022 Sep;22(2):178-182.
- doi: 10.17998/jlc.2022.06.10
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
-
Hur MH, Kim H, Lee JH
- KMID: 2534246
- J Liver Cancer.
- 2022 Sep;22(2):188-193.
- doi: 10.17998/jlc.2022.08.17
The Fontan operation is performed in patients with a single ventricle. As the systemic venous return is directly connected to the pulmonary circulation during this procedure, chronic hepatic congestion is... -
- CITED
-
- Close
- SHARE
-
- Close
- Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
-
Jo SJ, Rhu J, Kim JM, Choi GS, Joh JW
- KMID: 2534241
- J Liver Cancer.
- 2022 Sep;22(2):146-157.
- doi: 10.17998/jlc.2022.08.22
Background/Aim: Since the introduction of laparoscopy for liver resection in the 1990s, the performance of laparoscopic liver resection (LLR) has been steadily increasing. However, there is currently no data on... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
-
Kim S, Kim JH, Han JW, Jang JW, Choi JY, Yoon SK, Sung PS
- KMID: 2534248
- J Liver Cancer.
- 2022 Sep;22(2):202-206.
- doi: 10.17998/jlc.2022.09.17
Budd-Chiari syndrome (BCS) is defined by the obstruction of the hepatic venous outflow between the small hepatic veins and the junction of the inferior vena cava (IVC) with the right... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
-
Kim DH
- KMID: 2534236
- J Liver Cancer.
- 2022 Sep;22(2):93-102.
- doi: 10.17998/jlc.2022.03.28
Interventional oncology (IO) local therapies of hepatocellular carcinoma (HCC) can activate anti-cancer immunity and it is potentially leading to an anti-cancer immunity throughout the body. For the development of an... -
- CITED
-
- Close
- SHARE
-
- Close
- Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
-
Choi EJ, Kim YJ
- KMID: 2534237
- J Liver Cancer.
- 2022 Sep;22(2):103-114.
- doi: 10.17998/jlc.2022.09.08
Advances in our knowledge of the molecular characteristics of hepatocellular carcinoma (HCC) have enabled significant progress in the detection and therapeutic prediction of HCC. As a non-invasive alternative to tissue... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
-
Jang W, Lee HW, Lee JS, Kim BK, Kim SU, Park JY, Ahn SH, Kim DY
- KMID: 2534242
- J Liver Cancer.
- 2022 Sep;22(2):158-166.
- doi: 10.17998/jlc.2022.09.18
Background/Aim: The profile of patients with hepatocellular carcinoma (HCC) has changed globally; the role of etiology in predicting prognosis of HCC patients remains unclear. We aimed to analyze the characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report
-
Chang SH, Kim TS, Jeon YH, Jung NH, Choi DH
- KMID: 2534245
- J Liver Cancer.
- 2022 Sep;22(2):183-187.
- doi: 10.17998/jlc.2022.08.03
In recent years, radiotherapy (RT) has been used to treat hepatocellular carcinoma (HCC) at each stage. This clinical trend has developed with the increasing improvement of RT techniques, which show... -
- CITED
-
- Close
- SHARE
-
- Close
- Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
-
Jang JY, Jung J, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Park Jh, Yoon SM
- KMID: 2534240
- J Liver Cancer.
- 2022 Sep;22(2):136-145.
- doi: 10.17998/jlc.2022.08.18
Background/Aim: We aimed to investigate the efficacy and safety of stereotactic body radiation therapy (SBRT) in elderly patients with small hepatocellular carcinomas (HCC). Methods: Eighty-three patients (89 lesions) with HCC who... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
-
Kim CH, Choi GH, Na HY, Yoon CJ, Cho JY, Jang S, Kim JH, Jang ES, Kim JW, Jeong SH
- KMID: 2534247
- J Liver Cancer.
- 2022 Sep;22(2):194-201.
- doi: 10.17998/jlc.2022.08.24
Membranous obstruction of the inferior vena cava (MOVC) is a rare subset of Budd-Chiari syndrome (BCS) with a subacute onset that is often complicated by cirrhosis and hepatocellular carcinoma (HCC).... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
-
Ahn YH, Lee H, Han JE, Cho HJ, Cheong JY, Park B, Kim SS
- KMID: 2534239
- J Liver Cancer.
- 2022 Sep;22(2):125-135.
- doi: 10.17998/jlc.2022.05.24
Background/Aim: There has been a long-standing debate about the association of directacting antiviral (DAA) therapy and hepatocellular carcinoma (HCC) recurrence. This study aimed to investigate the association between DAA therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
-
Chang Y, Jeong SW, Jang JY, Eun H, Lee Y, Song DS, Yu SJ, Lee SH, Kim W, Lee HW, Kim SG, Ryu S, Park S
- KMID: 2534243
- J Liver Cancer.
- 2022 Sep;22(2):167-177.
- doi: 10.17998/jlc.2022.09.19
Background/Aim: New biomarkers are urgently needed to aid in the diagnosis of early stage hepatocellular carcinoma (HCC). We performed a meta-analysis on the diagnostic utility of circulating tumor DNA (ctDNA)... -
- CITED
-
- Close
- SHARE
-
- Close
- The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
-
Yoo JE, Nahm JH, Kim YJ, Jeon Y, Park YN
- KMID: 2534238
- J Liver Cancer.
- 2022 Sep;22(2):115-124.
- doi: 10.17998/jlc.2022.04.20
Background/Aim: Transforming growth factor-beta (TGF-β) has a dichotomous role, functioning as a tumor suppressor and tumor promoter. TGF-β signatures, explored in mouse hepatocytes, have been reported to predict the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
